SCHEMBL4819767

SCHEMBL4819767

CC1(C)CCN(C(=O)Cc2ccccc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.58
HSD11B1 P28845 3/20 0.56
ALDH1A1 P00352 5/20 0.54
TSHR P16473 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
KDM4E B2RXH2 3/20 0.50
HPGD P15428 1/20 0.50
USP2 O75604 1/20 0.50
GAA P10253 1/20 0.50
TP53 P04637 1/20 0.50
OPRD1 P41143 1/20 0.50
OPRK1 P41145 1/20 0.50
OPRM1 P35372 1/20 0.50
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TACR3 P29371 1/20 0.49
ME2 P23368 1/20 0.49
ME1 P48163 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4819750 1.00 CRBN (0.58) CRBNHSD11B1ALDH1A1TSHRL3MBTL1
SCHEMBL4814889 0.91 MAPT (0.59) CRBNHSD11B1ALDH1A1TSHRHPGD
SCHEMBL14297333 0.86 MEN1 (0.56) HSD11B1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL4817865 0.84 HSD11B1 (0.68) HSD11B1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4817875 0.84 HSD11B1 (0.68) HSD11B1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4817700 0.84 FAAH (0.56) ALDH1A1KDM4EUSP2GAALMNA
SCHEMBL4817713 0.84 FAAH (0.56) ALDH1A1KDM4EUSP2GAALMNA
SCHEMBL4818508 0.82 AR (0.55) ALDH1A1TSHRL3MBTL1MEN1KMT2A
SCHEMBL4820067 0.82 HSD11B1 (0.48) CRBNHSD11B1SMN1; SMN2
SCHEMBL4818498 0.82 AR (0.55) ALDH1A1TSHRL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US claimed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP claimed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO claimed
US-7402606-B2 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss SMITHKLINE BEECHAM CORPORATION (US) 2008-07-22 US disclosed
EP-1494663-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SmithKline Beecham Corporation (US) 2005-01-12 EP disclosed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO disclosed
WO-2003086385-A1 DERIVATIVES OF 1-(OXOAMINOACETYL) PENTYLCARBAMATE AS CATHEPSIN K INHIBITORS FOR THE TREATMENT OF BONE LOSS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-23 WO disclosed